The FDA (the US drug regulator) holds public expert panels before approving major new drugs. No psychedelic company has yet submitted the full package of evidence the FDA needs to even schedule one of these panels. This means no psychedelic drug is close to formal federal approval right now.
Absent a filed NDA with complete confirmatory data, there's nothing to convene on. The pipeline isn't at that stage yet.
Join our community — a free weekly Zoom circle with a master facilitator. Come sit with us first; the rest reveals itself.
Join the Free Weekly Circle →